166 related articles for article (PubMed ID: 26306070)
1. A Comparative Assessment of Quality of Platelet Concentrates Prepared by Buffy Coat Poor Platelet Concentrate Method and Apheresis Derived Platelet Concentrate Method.
Mallhi RS; Kumar S; Philip J
Indian J Hematol Blood Transfus; 2015 Dec; 31(4):453-9. PubMed ID: 26306070
[TBL] [Abstract][Full Text] [Related]
2. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods.
Singh RP; Marwaha N; Malhotra P; Dash S
Asian J Transfus Sci; 2009 Jul; 3(2):86-94. PubMed ID: 20808653
[TBL] [Abstract][Full Text] [Related]
3. Quality assessment of platelet concentrates prepared by platelet-rich plasma, buffy-coat, and apheresis methods in a tertiary care hospital in South India: A cross-sectional study.
Toora E; Kulkarni RG; Manivannan P; Sastry AS; Basavarajegowda A; Sahoo D
Asian J Transfus Sci; 2023; 17(2):239-245. PubMed ID: 38274963
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of different types of platelet concentrates in thrombocytopenic patients.
Singh RP; Marwaha N; Malhotra P; Dash S
Indian J Hematol Blood Transfus; 2008 Mar; 24(1):16-22. PubMed ID: 23100935
[TBL] [Abstract][Full Text] [Related]
6. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
Ali SF
Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
[TBL] [Abstract][Full Text] [Related]
8. Paired comparison of platelet concentrates prepared from platelet-rich plasma and buffy coats using a new technique with 111In and 51Cr.
Keegan T; Heaton A; Holme S; Owens M; Nelson E; Carmen R
Transfusion; 1992 Feb; 32(2):113-20. PubMed ID: 1542917
[TBL] [Abstract][Full Text] [Related]
9. Comparison of hematologic values and transforming growth factor-beta and insulin-like growth factor concentrations in platelet concentrates obtained by use of buffy coat and apheresis methods from equine blood.
Sutter WW; Kaneps AJ; Bertone AL
Am J Vet Res; 2004 Jul; 65(7):924-30. PubMed ID: 15281650
[TBL] [Abstract][Full Text] [Related]
10. Buffy coat pooled platelet concentrate: A new age platelet component.
Kumar R; Dhawan HK; Sharma RR; Kaur J
Asian J Transfus Sci; 2021; 15(2):125-132. PubMed ID: 34908742
[TBL] [Abstract][Full Text] [Related]
11. High platelet content can increase storage lesion rates following Intercept pathogen inactivation primarily in platelet concentrates prepared by apheresis.
Feys HB; Devloo R; Sabot B; De Pourcq K; Coene J; Compernolle V
Vox Sang; 2017 Nov; 112(8):751-758. PubMed ID: 28960339
[TBL] [Abstract][Full Text] [Related]
12. Are Buffy-coat Pooled Platelet Concentrates an Effective Alternative to Apheresis Platelet Concentrates? An
Agarwal P; Jain A; Elhence P; Verma A
Int J Appl Basic Med Res; 2023; 13(3):175-179. PubMed ID: 38023597
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of platelet concentrates prepared after two hours and overnight storage of buffy coat at room temperature.
Ojha S; Tirlotkar A; Gupta AM; S H S; Chavan P; Poojary M
Transfus Apher Sci; 2021 Feb; 60(1):103014. PubMed ID: 33262053
[TBL] [Abstract][Full Text] [Related]
14. Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates.
Wadhwa M; Krailadsiri P; Dilger P; Gaines Das R; Seghatchian MJ; Thorpe R
Vox Sang; 2002 Aug; 83(2):125-36. PubMed ID: 12201842
[TBL] [Abstract][Full Text] [Related]
15. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
Pietersz RN
Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
[TBL] [Abstract][Full Text] [Related]
16. Platelet storage lesion in interim platelet unit concentrates: A comparison with buffy-coat and apheresis concentrates.
Singh S; Shams Hakimi C; Jeppsson A; Hesse C
Transfus Apher Sci; 2017 Dec; 56(6):870-874. PubMed ID: 29126740
[TBL] [Abstract][Full Text] [Related]
17. [Qualitative comparison between buffy-coat-collected platelet concentrates and those by single-donor plateletpheresis].
Yu Y; Luo Q; Liu JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):878-81. PubMed ID: 17708824
[TBL] [Abstract][Full Text] [Related]
18. Defining an appropriate leucoreduction strategy by serial assessment of cytokine levels in platelet concentrates prepared by different methods.
Kaur D; Sharma RR; Marwaha N
Asian J Transfus Sci; 2015; 9(1):31-5. PubMed ID: 25722570
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo properties of various types of platelets.
Rebulla P
Vox Sang; 1998; 74 Suppl 2():217-22. PubMed ID: 9704448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
